PK Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a Phase I single-center, two-arm, open-label, randomized study in healthy HIV-negative women to evaluate the pharmacokinetics, safety, and bleeding patterns associated with 90-day use of matrix vaginal rings containing 200 mg Dapivirine and 320 mg Levonorgestrel.
Epistemonikos ID: 2dceee46f1e3010d7abdb05bc9a70f94f58f13f0
First added on: May 21, 2024